Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma

Clinical Advances in Hematology and Oncology

Volumn 3, Issue 4, 2005, Pages 297-299

  Zak, Dmitry ^a   Styler, Michael J ^a   Rosenbluth, Jonathan Z ^a   Brodsky, Isadore ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; RECURRENT CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CAMPTOTHECIN; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DOXORUBICIN; ETOPOSIDE; FEMORAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; IFOSFAMIDE; LEUCOVORIN; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; OSTEOSARCOMA; PALLIATIVE CARE; SALVAGE THERAPY; SCALP; SKIN NEOPLASMS; THORACOTOMY;

EID: 25844511183     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Zalupski M, Rankin C, Ryan J, Lucas D. Adjuvant therapy of osteosarcoma - a phase II trial: Southwest Ontology Group Study 9139. Cancer. 2004;100(4): 818-825.
2. Merimsky O, Meller I, Flusser G, et al. Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study. Cancer Chemother Pharmacol. 2000;45(2):177-181.
3. Okuno S, Edmonson J, Mahoney M, Buckner JC, Frytak S, Galanis E. Phase II trial of gemcitabine in advanced sarcomas. ECOG-E1797. Cancer. 2002;94(12):3225-3229.
4. Blaney S, Berg SL, Pratt C, Weitman S. A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. Clin Cancer Res. 2001;7(1):32-37.
5. Leu KM, Ostruszka LJ, Shewach D, et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of osteosarcoma. J Clin Oncol. 2004;22(9):1706-1712.
6. Ga Alfonso P, Sancho J, Mendez M, et al. Weekly irinotecan and gemcitabine as first line treatment in stage III or IV pancreatic cancer. A Goti cooperative group study. Proc Am Soc Clin Oncol. 2003;22:361. Abstract 1449.
7. Bahadori HR, Rocha Lima CM, Green MR, Safa AR. Synergistic effects of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell lines. Anticancer Res. 1999;19(6B):5423-5428.